We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Addex Therapeutics Ltd | LSE:0QNV | London | Ordinary Share | CH0029850754 | ADDEX THERAPEUTICS ORD SHS |
| Price Change | % Change | Share Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| 0.00 | 0.00% | 3.02 |
| High Price | Low Price | Open Price | Shares Traded | Last Trade |
|---|---|---|---|---|
| 180,000 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 1.42M | -20.8M | -0.2697 | -11.20 | 232.94M |
| Date | Time | Source | Headline |
|---|---|---|---|
| 19/4/2024 | 06:00 | UKREG | Addex to Present at the Swiss Biotech Day 2024 |
| 18/4/2024 | 06:00 | UKREG | Addex Therapeutics Reports Full Year 2023 Financial Results and Provides.. |
| 11/4/2024 | 06:00 | UKREG | Addex Therapeutics to Release Full-Year 2023 Financial Results and Host.. |
| 03/4/2024 | 06:00 | UKREG | Addex and Perceptive Launch Neurosterix with $63 Million to Accelerate.. |
| 14/3/2024 | 06:00 | UKREG | Addex to Present at the Bio-Europe Spring 2024 Conference |
| 31/1/2024 | 06:00 | UKREG | Addex Enters into At-The-Market ADS Offering Agreement with H.C. Wainwright.. |
1 Year Addex Therapeutics Chart |
Intraday Addex Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
